Hiperbarik ropivakain kısa süreli bekleme ile yeterli unilateral spinal anestezi sağlar mı?
Günübirlik cerrahi anestezide diğer lokal anesteziklere alternatif bulmak amacıyla hiperbarik ropivakaini tek taraflı spinal anestezi uygulamalarında hiperbarik bupivakain ile karşılaştırmayı amaçladık. Bu randomize çift kör çalışma, ASAI-II grubuna dahil tek taraflı atroskopik diz cerrahisi geçirecek 40 hasta üzerinde yapıldı. Hastalar rastgele iki gruba ayrılarak Grup R'ye 3 mL %0.5'lik ropivakain (15 mg ropivakain + 240 mg dekstroz), Grup B'ye 3 mL %0.5'lik bupivakain (15 mg bupivakain + 240 mg dekstroz) intratekal olarak verildi. Spinal anestezi lateral dekübit pozisyon ve¬rilerek L3-4 aralığından gerçekleştirildi. Lateral dekübit pozisyonu 5 dakika korunduktan sonra hastalar sırt üstü (supine) pozisyona çevrildiler. Duyu bloğu pinprick testi, motor blok Modifiye Bromage Skorlaması (MBS) kullanılarak değerlendirildi Her iki grupta da ipsilateral ve kontralateral duyu bloğu seviyesi T9'a ulaştı. Medyan MBS ipsilateral tarafta her iki grupta da 1 idi (p>0.05). Grup B'de kontralateral taraftaki medyan MBS= 1 iken, Grup R'de medyan MBS= 4 idi (p
Does hyperbaric ropivacaine provide adequate unilateral spinal anaesthesia?
In order to find an alternative to other local anaesthetics, we used hyperbaric ropivacaine for unilateral spinal anaesthesia in outpatient surgery. This prospective randomized study was conducted on 40 ASA I-II patients that were assigned for arthroscopic knee surgery. Patients were separated randomly into two groups. Group R received 3 mL ropivacaine 0.5% (ropivacaine 15 mg + dextrose 240 mg) and group B received 3 mL bupivacaine 0.5% (bupivacaine 15mg + dextrose 240 mg) intrathecally through the L3-4 intervertebral space in the lateral position. After staying in a lateral position for 5 minutes, patients were placed supine. Sensory and motor block were controlled with a pinprick test and Modified Bromage Scale (MBS), respectively. in both study groups, ipsilateral and contralateral sensory block reached the T9 level. The ipsilateral median MBS was 1 in both groups (p>0.05). The contralateral median MBS was 1 in group B and was 4 in group R (p<0.05). The mean sensory block duration was 200±22 min in group B and 148±24 min in group R. The mean motor block duration was 16±48 min group B and 97±38 min in group R (p<0.05). Hyperbaric ropivacaine could be an alternative to hyperbaric bupivacaine due to the shorter duration of actionfor unilateral spinal anaesthesia in outpatient surgical operations of lower extremities. The lateral stay period can be decreased, which may lead to a shorter anesthesia time.
___
- 1. Fanelli G, Borghi B, Casati A et al. Unilateral bupivacaine spinal anesthesia for outpatient knee arthroscopy. Can J Anaest 2000; 47(8): 746-51.
- 2.Pavlin DJ, Rapp SE, Polissar NL et al. Factors affecting discharge time in adult outpatients. Anesth Analg 1998; 87(4): 816-26.
- 3. Urmey WF, Stanton J, Peterson M, et al. Combined spinal-epidural anesthesia for outpatient surgery: dose-response characteristics of intrathecal isobaric lidocaine using a 27-gauge Whitcare spinal needle. Anesthesiology 1995; 83: 528-34.
- 4. Liu SS, Pollock JE, Mulroy FE, et al. Comparison of 5% with dextrose, 1.5% with dextrose, and 1.5% dextrose-free lidocaine solutions for spinal anesthesia in human volunteers. Anesth Analg 1995; 81: 697-702.
- 5. Gaiser RR. Should intrathecal lidocaine be used in the 21st century? J Clin Anesth 2000; 12: 476-81.
- 6. Hodgson PS, Lui SS. Procaine compared to lidocaine for incidence of transient neurologic symptoms: Reg Anesth Pain Med 2000; 25(3):218-22.
- 7. Zayas VM, Liguori GA, Chisholm MF, et al. Dose response relationships for isobaric spinal mepivacaine using the combined spinal epidural technique. Anesth Analg 1999; 89: 1167-71.
- 8. Martinez-Bourio R, Arzuaga M, Quintana JM, et al. Incidence of transient neurologic symptoms after hyperbaric subarachnoid anesthesia with 5% lidocaine and 5% prilocaine. Anesthesiology 1999; 90(1): 323-6.
- 9. Gautier Ph E, Kock MD, Steenberge AV, et al. Intrathecal ropivacaine for ambulatory surgery: a comparison between intrathecal bupivacaine and intrathecal ropivacaine for knee arthroscopy. Anesthesiology 1999; 91: 1239-45.
- 10. McNamee DA, McClelland AM, Scott S, Milligan KR, Westman L, Gustafsson U. Spinal anaesthesia: comparison of plain ropivacaine with bupivacaine 5 mg ml"1 for major orthopaedic surgery. Br J Anaesth 2002; 89(5):702-6.
- 11. McDonald SB. Hyperbaric spinal ropivacaine. Anesthesiology 1999; 90: 971-7.
- 12. Hodgson PS, Neal JM, Pollock JE, et al. The neurotoxicity of drugs given intrathecally (spinal). Anesth Analg 1999; 88: 797-809.
- 13. Pollock JE, Neal JM, Stephenson CA, et al. Prospective study of the incidence of transient radicular irritation in patients undergoing spinal anesthesia. Anesthesiology 1996; 84: 1361-7.
- 14. De Weert K, Traksel M, Gielen M, et al. The incidence of transient neurological symptoms after spinal anesthesia with lidocaine compared to prilocaine. Anaesthesia 2000;5 5(10): 1020-4.
- 15. Liguori GA, Zayas VM, Chisholm MF. Transient neurologic symptoms after spinal anesthesia with mepivacaine and lidocaine. Anesthesiology 1998; 88: 619-23.
- 16. Ben-David B, Levin H, Solomon E et al. Spinal bupivacaine in ambulatory surgery: the effect of saline dilution. Anesth Analg 1996; 83: 716-20.
- 17. Ben-David B, Solomon E, Levin H et al. Intrathecal fentanyl with small-dose dilute bupivacaine: better anesthesia without prolonging recovery. Anesth Analg 1997; 85: 560-5.
- 18. Malinovsky JM, Charles F, Kick O. et al. Intrathecal Anesthesia: Ropivacaine Versus Bupivacaine Anesth Analg 2000; 91: 1457-60.
- 19.Whiteside JB, Burke D, Wildsmith JAW. Comparison of ropivacaine 0.5% (in glucose 5%) with bupivacaine 0.5% (in glucose 8%) for spinal anaesthesia for elective surgery. Br J Anaesth 2003; 90(3): 304-8.
- 20. Markham A, Faulds D. Ropivacaine: A review of its pharmacology and therapeutic use in regional anesthesia. Drugs 1996;52(4): 29-49.
- 21. Wildsmith JAW, McClure JH, Brown DT et al. Effects of posture on the spread of isobaric and hyperbaric amethocaine. Br J Anaesth 1981; 53: 273-8.
- 22. Salvaj G, Gamulin Z, Schweizer A et al. Influence of duration of lateral position during spinal anesthesia on distribution of hyperbaric tetracaine. Anesthesiology 1990; 73 (3 suppl): A 852.
- 23. Povey HMR, Jocopsen J, Westergaard N. Subarachnoid analgesia with hyperbaric 0.5 % bupivacaine: effect of a 60 min period of sitting. Acta Anaesthesiol Scand 1989: 33: 295-7.
- 24. Andrea C, Guido F, Giorgio A, et al. Frequency of hypotension during conventional or asymmetric hyperbaric spinal block. Reg Anesth Pain Med 1999; 24(3): 214-9.
- 25. Guido F, Battista B, Andrea C, et al. Unilateral bupivacaine spinal anaesthesia for outpatient knee arthroscopy. Can J Anaesth 2000; 47(8): 746-51.
- 26. Lui SS, Ware PD, Allen HW et al. Dose-response characteristics of spinal bupivacaine in volunteers: clinical implications for ambulatory anesthesia. Anesthesiology 1996: 85: 729-36.